Royalty Pharma PLC
(MEX:RPRX)
MXN
528.5
0 (0%)
Market Cap: 229.61 Bil
Enterprise Value: 416.39 Bil
PE Ratio: 10.02
PB Ratio: 1.66
GF Score: 72/100 Royalty Pharma PLC at Evercore ISI HealthCONx Conference Transcript
Nov 28, 2023 / 08:00PM GMT
Release Date Price:
MXN530
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Okay. Thank you all being here. Pleasure to have Royalty Pharma management team with us. I want to kick things off. But just before I do, should I maybe turn it over to Terry to start us off and we will jump right into it.
Terrance Coyne
Royalty Pharma plc - Executive VP & CFO
Yes, sure. Well thanks, Umer. Thanks for having us today, and thanks to everyone at Evercore. We're really excited to be here and answer all of your questions.
Michael DiFiore
Evercore ISI Institutional Equities, Research Division - Equity Research Analyst
Excellent. Say, before we dive into questions, maybe give a general overview of where Royalty Pharma stands now and what's maybe in store for the future?
Terrance Coyne;Umer Raffat
Royalty Pharma plc - Executive VP & CFO;Evercore ISI Institutional Equities, Research
Yes. So well...
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot